GFRAL was initially thought to be expressed exclusively in brain tissues; however, some subsequent studies revealed that it is also expressed in pancreatic cancer cells, prostate cancer cells, and vascular endothelial cells [34,35,36]. Here, GFRAL is linked to prostate carcinoma.